Difference between revisions of "Team:BIT/cs"

Line 1: Line 1:
−
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7" lang=""> <![endif]-->
+
<!DOCTYPE HTML>
−
<!--[if IE 7]>        <html class="no-js lt-ie9 lt-ie8" lang=""> <![endif]-->
+
−
<!--[if IE 8]>        <html class="no-js lt-ie9" lang=""> <![endif]-->
+
−
<!--[if gt IE 8]><!-->
+
 
<html class="no-js" lang="">
 
<html class="no-js" lang="">
 
<!--<![endif]-->
 
<!--<![endif]-->
 
<head>
 
<head>
−
 
−
 
 
<meta charset="utf-8">
 
<meta charset="utf-8">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
Line 78: Line 73:
 
   
 
   
 
</head>
 
</head>
−
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_BIT skin-igem action-view">
 
−
 
−
        <script type='text/javascript'        src ='/common/tablesorter/jquery.tablesorter.min.js'></script>
 
−
        <link rel='stylesheet' type='text/css' href='/common/tablesorter/themes/groupparts/style.css' />
 
−
        <link rel='stylesheet' type='text/css' href='/common/table_styles.css' />
 
−
 
−
        <script type='text/javascript'        src ='/wiki/skins/Igem/resources/2017_skin.js'></script>
 
−
 
−
 
−
    <div id='globalWrapper'>
 
−
        <div id='top_menu_under' class='noprint'></div>
 
−
        <div id='top_menu_14' class='noprint'>Loading menubar.....</div> <!-- Will be replaced with the jQuery.load -->
 
−
<script>jQuery('#top_menu_14').load('https://2017.igem.org/cgi/top_menu_14/menubar_reply.cgi',
 
−
    {  t:"Team%3ABIT",
 
−
a:"View+%2FTeam%3ABIT++Edit+%2Fwiki%2Findex.php%3Ftitle%3DTeam%3ABIT%26action%3Dedit++History+%2Fwiki%2Findex.php%3Ftitle%3DTeam%3ABIT%26action%3Dhistory++Move+%2FSpecial%3AMovePage%2FTeam%3ABIT++Unwatch+%2Fwiki%2Findex.php%3Ftitle%3DTeam%3ABIT%26action%3Dunwatch%26token%3Dd287ad54aadbd55a8dc781d867df3847%252B%255C++Page+%2FTeam%3ABIT++Discussion+%2Fwiki%2Findex.php%3Ftitle%3DTalk%3ATeam%3ABIT%26action%3Dedit%26redlink%3D1++" });
 
−
</script>
 
−
 
−
        <!-- Content div contains HQ_page for HQ styles, Logo and title div, and USER CONTENT -->
 
−
<div id="content" class="mw-body" role="main">
 
−
    <a id="top"></a>
 
−
 
−
            <div id="top_title">
 
−
                <div class="logo_2017">
 
−
                    <a href="https://2017.igem.org">
 
−
                    <img src="https://static.igem.org/mediawiki/2017/8/8b/HQ_page_logo.jpg" width="100px">
 
−
                    </a>
 
−
                </div>
 
−
 
−
        <h1 id="firstHeading" class="firstHeading">
 
−
            <span dir="auto">Team:BIT</span>
 
−
        </h1>
 
−
            </div>
 
−
 
−
            <div id="HQ_page">
 
−
                <div id="bodyContent">
 
−
            <div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><p>
 
−
<!--<![endif]-->
 
−
<head>
 
−
 
−
 
−
<meta charset="utf-8">
 
−
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
−
<meta name="viewport" content="width=device-width, initial-scale=1">
 
−
<!-- 上述3个meta标签*必须*放在最前面, 任何其他内容都*必须*跟随其后！ -->
 
−
 
−
<title>Dsign - Minimal portfolio Bootstrap template</title>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/bootstrap/min/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/flexslider/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/jquery.fancybox/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/main/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/responsive/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/min/CSS?action=raw&amp;ctype=text/css"/>
 
−
<link rel="stylesheet" href="css/font-icon.css">
 
−
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.4.0/css/font-awesome.min.css">
 
−
 
−
 
−
<!-- Animate.css -->
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/CSS?action=raw&amp;ctype=text/css"/>
 
−
<!-- Icomoon Icon Fonts-->
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/font-icon/CSS?action=raw&amp;ctype=text/css"/>
 
−
<!-- Bootstrap  -->
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/bootstrap/CSS?action=raw&amp;ctype=text/css"/>
 
−
<!-- Flexslider  -->
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/flexslider/CSS?action=raw&amp;ctype=text/css"/>
 
−
 
−
<!-- Theme style  -->
 
−
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/style/CSS?action=raw&amp;ctype=text/css"/>
 
−
<style>
 
−
 
−
 
−
        /*以下CSS用于解决iGEM官网坑爹样式问题*/
 
−
        body {
 
−
            height: 100%;
 
−
            width: 100%;
 
−
            font-family: 'Helvetica', 'Arial', 'Verdana', sans-serif;
 
−
            background-color: rgba(242,215,188,0.4);
 
−
        }
 
−
        #globalWrapper{
 
−
            margin: 0;
 
−
            padding: 0;
 
−
        }
 
−
        #content{
 
−
            width: 100%;
 
−
            padding: 0;
 
−
            margin: -12px 0 0;
 
−
        }
 
−
 
−
      #HQ_page p {
 
−
    font-family: "Arial",Helvetica,sans-serif;
 
−
    font-size: 13px;
 
−
    text-align: center;
 
−
 
−
        #top_title{
 
−
            display: none;
 
−
        }
 
−
        #sideMenu{
 
−
            display: none;
 
−
        }
 
−
      #content,
 
−
      .vs-content,
 
−
      .vs-wrapper section {
 
−
        background-color: transparent !important;
 
−
      }
 
−
      .my-backTop:visited {
 
−
        color: #F8A886 !important;
 
−
      }
 
−
        /*以上CSS用于解决iGEM官网坑爹样式问题*/
 
−
</style>
 
−
 
 
</head>
 
</head>
−
<body>
+
<body>
 
 
  
Line 203: Line 89:
 
<div class="col-xs-10 text-right menu-1">
 
<div class="col-xs-10 text-right menu-1">
 
<ul>
 
<ul>
−
<li class="active"><a href="home.html">Home</a></li>
+
<li class="active"><a href="目录.html">Home</a></li>
−
+
<li><a href="../portfolio.html">Practice</a></li>
 
<li class="has-dropdown">
 
<li class="has-dropdown">
−
<a href="#">Blo</a>
+
<a href="../blog.html">Blo</a>
 
<ul class="dropdown">
 
<ul class="dropdown">
−
<li><a href="design.html">Design</a></li>
+
<li><a href="#">Design</a></li>
−
<li><a href="demonstrate.html">Demonstrate</a></li>
+
<li><a href="#">Demonstrate</a></li>
−
<li><a href="model.html">Model</a></li>
+
<li><a href="#">Model</a></li>
 
</ul>
 
</ul>
−
  </li><li><a href="practice.html">Practice</a></li>
+
</li>
−
<li><a href="Achievement.html">Achievement</a></li>
+
<li><a href="../about.html">Achievement</a></li>
−
<li><a href="notebook.html">Notebook</a></li>
+
<li><a href="../contact.html">Notebook</a></li>
 
<li class="btn-cta"><a href="#"><span>Team</span></a></li>
 
<li class="btn-cta"><a href="#"><span>Team</span></a></li>
 
</ul>
 
</ul>
Line 223: Line 109:
 
</div>
 
</div>
 
</nav>
 
</nav>
−
    <div id="fh5co-blog">
+
 +
<div id="fh5co-blog">
 
<div class="container">
 
<div class="container">
 
<div class="row animate-box">
 
<div class="row animate-box">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
−
    <h2>Abstract</h2>
+
<h2>Market Analysis</h2>
 
<p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities.  
 
<p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities.  
 
Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research.
 
Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research.
 
From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.  
 
From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.  
 
</p>
 
</p>
−
</div>
+
</div>
 +
</div>
 +
</div>
 +
</div>
 
 
−
       
+
<div class="第一段">
−
<div id="fh5co-wireframe">
+
−
<div class="container">
+
 
<div class="row animate-box">
 
<div class="row animate-box">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
−
<h2>Market Analysis</h2>
+
<h2>Wireframe Connects the Underlying Conceptual Structure</h2>
 
</div>
 
</div>
 
</div>
 
</div>
Line 245: Line 133:
 
<div class="col-md-5 animate-box">
 
<div class="col-md-5 animate-box">
 
<div class="user-frame">
 
<div class="user-frame">
−
<h3>1. Grand Marke</h3>
+
<h3>Wireframe Connects the Underlying Conceptual Structure</h3>
−
<p>a. JACOB falls in the category of in vitro diagnostic devices, particularly serum biomarker detection. Diagnosis market is characterized by inelastic demanding and steady growth. </p>
+
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
−
+
<span>Louie Jie Mahusay</span><br>
 +
<small>CEO, Founder</small>
 
</div>
 
</div>
 
</div>
 
</div>
 
<div class="col-md-7 animate-box">
 
<div class="col-md-7 animate-box">
−
<p>According to the International Trade Administration, medical device market is forecasted to grow $20 Billion per year after 2017, along with constant growth of population. For United States solely, In Vitro diagnostic devices made up 14.7% of total medical device export in 2015, while keep increasing, currently ranked 4th among all categories. Such market is advantageous to the commercialization of JACOB.（可以加到市场调研里面） </p>
+
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
−
+
<blockquote>
 +
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
 +
</blockquote>
 +
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
 
</div>
 
</div>
 
</div>
 
</div>
−
+
</div>
−
    <center>
+
</div>
  
 
   <p><img src="../../2222/images/qy1.jpg" alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"><img src="../../2222/images/qy1.jpg" alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"></p>       
 
   <p><img src="../../2222/images/qy1.jpg" alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"><img src="../../2222/images/qy1.jpg" alt="Free HTML5 Bootstrap Template" class="img-responsive img-rounded"></p>       
−
</center>
+
 
−
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
+
<div id="fh5co-blog">
−
  <h2>SWOT Analysis</h2>
+
<div class="container">
−
</div>
+
<div class="row animate-box">
 +
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 +
<h2>Market Analysis</h2>
 +
 
    
 
    
−
    <p>&nbsp;</p>
+
 
−
  <p>&nbsp;</p>
+
−
  <p>&nbsp;</p>
+
 
   <p>&nbsp;</p>
 
   <p>&nbsp;</p>
 
   <p>&nbsp;</p>
 
   <p>&nbsp;</p>
Line 315: Line 208:
 
&nbsp;&nbsp; Comparing to technology equipped by clinics and hospitals, The use of adjustable aptamer and genetic modified microbes made JACOB more economical, adaptable, and stable. The integration of automated proceeding made JACOB more user-friendly and portable. JACOB does not need professional physicians reading results, behaving like glucose meter but less risky. In China it is likely to be deployed in units of household or local communities. Similarly, for United States the Food and Drug Administration classified the core mechanism of JACOB as Class I medical device (if designed to not detecting cancer biomarkers), means no premarketing control is required. It is worth noting though, Chinese in vitro diagnostic market is relatively new and have few competitors. Those few players can no longer support the concrete increasing demand for medical cares. Chinese government had ratified a great number of acts as well as guidelines and simplified documents examining and approval process to encourage innovation in the field of medical devices, which offers our team a great market environment. </p>
 
&nbsp;&nbsp; Comparing to technology equipped by clinics and hospitals, The use of adjustable aptamer and genetic modified microbes made JACOB more economical, adaptable, and stable. The integration of automated proceeding made JACOB more user-friendly and portable. JACOB does not need professional physicians reading results, behaving like glucose meter but less risky. In China it is likely to be deployed in units of household or local communities. Similarly, for United States the Food and Drug Administration classified the core mechanism of JACOB as Class I medical device (if designed to not detecting cancer biomarkers), means no premarketing control is required. It is worth noting though, Chinese in vitro diagnostic market is relatively new and have few competitors. Those few players can no longer support the concrete increasing demand for medical cares. Chinese government had ratified a great number of acts as well as guidelines and simplified documents examining and approval process to encourage innovation in the field of medical devices, which offers our team a great market environment. </p>
 
  <div id="fh5co-wireframe">
 
  <div id="fh5co-wireframe">
−
<div class="container">
+
</div>
 +
</div>
 +
</div>
 +
</div>
 +
 +
<div class="第一段">
 
<div class="row animate-box">
 
<div class="row animate-box">
−
  <div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
+
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
−
<h2>3. Customer Study</h2>
+
<h2>Wireframe Connects the Underlying Conceptual Structure</h2><p>In market analysis we had solved many issues regarding our project background, but also generated more questions about operability. To obtain a better answer, we had visited 北京永翰星港生物技术有限公司和博奥生物芯片公司. </p>
 
</div>
 
</div>
−
<p>&nbsp;</p>
 
−
<p>&nbsp;</p>
 
−
  <p>&nbsp;</p>
 
−
<p>we performed two types of investigations: on different age groups, and on people who participated traditional health examination. </p>
 
 
</div>
 
</div>
 
<div class="row">
 
<div class="row">
 
<div class="col-md-5 animate-box">
 
<div class="col-md-5 animate-box">
 
<div class="user-frame">
 
<div class="user-frame">
−
<h3>a. Survey on Different Age Groups:</h3>
+
<h3></h3>
−
<p> </p>
+
<p>We asked 蓝晶 mainly on how to construct a viable procedure to industrialize JACOB. Our plan for JACOB after the iGEM jamboree is divided into developments, commercialization, and resource transformation. For development we currently divided it into small, medium, large scale trial. Based on our current knowledge, small and medium trial is planned as below </p>
−
+
<span>Louie Jie Mahusay</span><br>
−
</div>
+
<small>CEO, Founder</small>
−
</div>
+
−
<div class="col-md-7 animate-box">
+
−
<p>b. Survey on Participants of Traditional Health Examination:<br>
+
−
i. To better understand Beijing Institute of Technology's student body's attitude and knowledge about medical examination, our team interviewed staff and students participated in medical examination at Beijing Institute of Technology School Hospital on 7 September 2017. For further info please refer to this. (在这里加一个超链接连到校医院采访的页面)<br>
+
−
ii. The result confirm that no one is willing to take bad health, but they simply are not informed. A "stimulus" is needed to warn them potential health issues and prompt patients to visit healthcare. This again reinforce that our main market role is to warn patients and help diagnosis, not to compete for decisive diagnosis. Therefore we came down to build up JACOB's convenience, efficiency, and affordability instead of optimizing sensitive and specificity.
+
−
） </p>
+
−
</div>
+
−
<div class="row animate-box">
+
−
  <div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
+
−
<h2>Industry Research</h2>
+
−
</div>
+
−
<p>&nbsp;</p>
+
−
<p>&nbsp;</p>
+
−
  <p>&nbsp;</p><p>In market analysis we had solved many issues regarding our project background, but also generated more questions about operability. To obtain a better answer, we had visited 北京永翰星港生物技术有限公司和博奥生物芯片公司. </p>
+
−
</div>
+
−
<div class="row">
+
−
<div class="col-md-5 animate-box">
+
−
<div class="user-frame">
+
−
  <h3></h3>
+
−
  <p>We asked 蓝晶 mainly on how to construct a viable procedure to industrialize JACOB. Our plan for JACOB after the iGEM jamboree is divided into developments, commercialization, and resource transformation. For development we currently divided it into small, medium, large scale trial. Based on our current knowledge, small and medium trial is planned as below </p>
+
−
+
 
</div>
 
</div>
 
</div>
 
</div>
 
<div class="col-md-7 animate-box">
 
<div class="col-md-7 animate-box">
 +
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
 +
<blockquote>
 +
<p>Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. </p>
 +
</blockquote>
 
<p><span class="label-warning">1. Small Scale Trial</span><br>
 
<p><span class="label-warning">1. Small Scale Trial</span><br>
 
                     &nbsp;&nbsp;&nbsp; a. Duration: About half year
 
                     &nbsp;&nbsp;&nbsp; a. Duration: About half year
Line 371: Line 248:
 
b. When the production of microfluidic chip is resolved, how to prepare it for using will be on the agenda. Currently the chip we used for final packaging needs to be soaked in ethyl alcohol and acetone for about one hour, which pose a question for mass production. </p>
 
b. When the production of microfluidic chip is resolved, how to prepare it for using will be on the agenda. Currently the chip we used for final packaging needs to be soaked in ethyl alcohol and acetone for about one hour, which pose a question for mass production. </p>
 
</div>
 
</div>
−
<p>We asked 博奥 mainly on how to control the cost of microfluidic chip production¬. From their experience we found that chips cost much more in the early development, but its cost diminishes quickly in later stages when mass production is reached, ranging from $0.1 to few dollars. However, there exist a conflict of material. In the iGEM version we picked optical cement instead of PMDS for its advantages of adequate solidification speed, feasibility, bio-inertia, and precision of altitude. However, PMDS production industries are much more matured. There is currently no companies offering mass production of optical cement microfluidic chips. Thus, we must decide the better material. </p>
+
<p>We asked 博奥 mainly on how to control the cost of microfluidic chip production¬. From their experience we found that chips cost much more in the early development, but its cost diminishes quickly in later stages when mass production is reached, ranging from $0.1 to few dollars. However, there exist a conflict of material. In the iGEM version we picked optical cement instead of PMDS for its advantages of adequate solidification speed, feasibility, bio-inertia, and precision of altitude. However, PMDS production industries are much more matured. There is currently no companies offering mass production of optical cement microfluidic chips. Thus, we must decide the better material.</p>
−
<div id="fh5co-started">
+
</div>
 +
</div>
 +
</div>
 +
</div>
 +
 
 +
 
 +
<div id="fh5co-started">
 
  <div class="overlay"></div>
 
  <div class="overlay"></div>
 
<div class="container">
 
<div class="container">
Line 434: Line 317:
 
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
 
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
 
</div>
 
</div>
−
<div/>
 
−
<!-- portfolio section -->
 
−
  <!-- footer -->
 
−
<footer class="section footer">
 
−
  <div class="footer-bottom"> </div>
 
−
</footer>
 
−
<div class="gototop js-top">
 
−
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
 
−
</div>
 
−
<!-- footer -->
 
 
<!-- JS FILES -->  
 
<!-- JS FILES -->  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  
Line 461: Line 334:
 
<script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&amp;ctype=text/javascript"></script>
 
<script src="https://2017.igem.org/Template:BIT/main/Javascript?action=raw&amp;ctype=text/javascript"></script>
  
−
 
+
</body>
−
</body>
+
−
 
+
−
</p>
+
−
<!--
+
−
NewPP limit report
+
−
CPU time usage: 0.002 seconds
+
−
Real time usage: 0.002 seconds
+
−
Preprocessor visited node count: 4/1000000
+
−
Preprocessor generated node count: 40/1000000
+
−
Post‐expand include size: 0/2097152 bytes
+
−
Template argument size: 0/2097152 bytes
+
−
Highest expansion depth: 2/40
+
−
Expensive parser function count: 0/100
+
−
-->
+
−
 
+
−
<!-- Saved in parser cache with key 2017_igem_org:pcache:idhash:6063-0!*!*!*!*!*!* and timestamp 20171026182839 and revision id 215523
+
−
-->
+
−
</div>             <div class="visualClear"></div>
+
−
            </div>
+
−
    </div>
+
−
 
+
−
        </div>
+
−
 
+
−
        <!-- Side Menubar -->
+
−
        <div id="sideMenu">
+
−
            <a href="https://2017.igem.org">
+
−
                <div id="home_logo" >
+
−
                <img src="https://static.igem.org/mediawiki/2017/b/bf/HQ_menu_logo.jpg">
+
−
                </div>
+
−
            </a>
+
−
 
+
−
            <div style="clear:both; height:5px;"></div>
+
−
 
+
−
            <div id="menuDisplay"></div>  <!- Menu will be loaded here ->
+
−
        </div>
+
−
 
+
−
        <!-- Pop_Why Div is definded here -->
+
−
        <div class="pop_why_cover"></div>
+
−
 
+
−
        <div class="pop_why_box" >
+
−
            <div class="pop_close">× </div>
+
−
            <div class="pop_why_content"><h3> Loading ... </h3></div>
+
−
        </div>
+
−
 
+
−
    </div>
+
 
</html>
 
</html>

Revision as of 20:26, 26 October 2017

<!DOCTYPE HTML> Dsign - Minimal portfolio Bootstrap template

Market Analysis

This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research. From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.

Wireframe Connects the Underlying Conceptual Structure

Wireframe Connects the Underlying Conceptual Structure

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

Louie Jie Mahusay
CEO, Founder

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts. far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

Free HTML5 Bootstrap TemplateFree HTML5 Bootstrap Template

Market Analysis

 

 

 

 

a. Four Aspects:
   i. Strength:
         1. Convenience.
         2. Adaptability.
         3. High Cost/Performance Ratio.
         4. Inelastic to change in test conditions.
   ii. Weakness:
         1. Technology Barrier.
         2. Branding Barrier.
         3. Strict Market Admittance Criteria.
         4. Distribution Barrier.
   iii. Opportunity:
         1. Favorable national economic condition.
         2. Positive national policies.
         3. Uprising Health-consciousness.
   iv. Threats:
        1. Well-established industries control the high-end markets with related products.
        2. Industrial chain is currently complete
        3. Technological applications are matured

b. Comments:
   Comparing to technology equipped by clinics and hospitals, The use of adjustable aptamer and genetic modified microbes made JACOB more economical, adaptable, and stable. The integration of automated proceeding made JACOB more user-friendly and portable. JACOB does not need professional physicians reading results, behaving like glucose meter but less risky. In China it is likely to be deployed in units of household or local communities. Similarly, for United States the Food and Drug Administration classified the core mechanism of JACOB as Class I medical device (if designed to not detecting cancer biomarkers), means no premarketing control is required. It is worth noting though, Chinese in vitro diagnostic market is relatively new and have few competitors. Those few players can no longer support the concrete increasing demand for medical cares. Chinese government had ratified a great number of acts as well as guidelines and simplified documents examining and approval process to encourage innovation in the field of medical devices, which offers our team a great market environment.

Wireframe Connects the Underlying Conceptual Structure

In market analysis we had solved many issues regarding our project background, but also generated more questions about operability. To obtain a better answer, we had visited 北京永翰星港生物技术有限公司和博奥生物芯片公司.

We asked 蓝晶 mainly on how to construct a viable procedure to industrialize JACOB. Our plan for JACOB after the iGEM jamboree is divided into developments, commercialization, and resource transformation. For development we currently divided it into small, medium, large scale trial. Based on our current knowledge, small and medium trial is planned as below

Louie Jie Mahusay
CEO, Founder

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts far from the countries Vokalia and Consonantia, there live the blind texts.

1. Small Scale Trial
    a. Duration: About half year
    b. We will choose the production method for JACOB, e.g. as we learned from 永翰星港, the "filtration" of aptamers are still expensive, but aptamers synthesis is more economical. Nine sets of known aptamer (90np, 15 microliter, 100nmol/L) costs only about $135, and every set is sufficient for 250 microfluidic chips.
    c. During this phase we also need to rule out unknown influences on the device caused by switching to new assembly conditions, such as switching to fermentation flask instead of tightly controlled experiment chamber.
    d. During this phase preserving microbes will greatly affect the cost of production, and affordability is one of the most important characteristics of JACOB.
2. Medium Scale Trial
    a. Duration: 4-5 months
    b. When the production of microfluidic chip is resolved, how to prepare it for using will be on the agenda. Currently the chip we used for final packaging needs to be soaked in ethyl alcohol and acetone for about one hour, which pose a question for mass production.

We asked 博奥 mainly on how to control the cost of microfluidic chip production¬. From their experience we found that chips cost much more in the early development, but its cost diminishes quickly in later stages when mass production is reached, ranging from $0.1 to few dollars. However, there exist a conflict of material. In the iGEM version we picked optical cement instead of PMDS for its advantages of adequate solidification speed, feasibility, bio-inertia, and precision of altitude. However, PMDS production industries are much more matured. There is currently no companies offering mass production of optical cement microfluidic chips. Thus, we must decide the better material.

Hire Us!

Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.

Contact Us